Clinical characteristics, management and outcomes of patients with chronic heart failure: Results from the heart function assessment registry trial in S audi Arabia (HEARTS-chronic)

AlHabeeb, Waleed; Elasfar, Abdelfatah; Albackr, Hanan; Alshaer, Fayez; Almasood, Ali; AlFaleh, Hussam; Kashour, Tarek; Hersi, Ahmad; Asfina, Kazi Nur; Altaradi, Hani; AlShaqhaa, Waleed; AlAyoubi, Fakhr; AlHabib, Khalid F.

doi:10.1016/j.ijcard.2017.02.087

Cited by 26 publications

(34 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, we sought, via this observational study, to assess the prognostic value of hyponatremia in a sample of CHF patients in Saudi Arabia, especially after a recently developed regional registry began to give essential information about this population to be of younger age, with higher rates of diabetes mellitus (DM), and with predominant left ventricular systolic dysfunction. 14…”

Section: Introductionmentioning

confidence: 99%

<p>Predictors of Mortality in Patients with Chronic Heart Failure: Is Hyponatremia a Useful Clinical Biomarker?</p>

Alem¹

2020

IJGM

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

<p>Predictors of Mortality in Patients with Chronic Heart Failure: Is Hyponatremia a Useful Clinical Biomarker?</p>

Alem¹

2020

IJGM

View full text Add to dashboard Cite

show abstract

“…A more recent study (HEARTS-chronic) evaluating the clinical features and outcomes of 685 CHF patients enrolled in the registry between 2009 and 2011 reported that CHF patients presented young and commonly suffered from severe LV dysfunction [4]. For instance, the mean age at diagnosis of patients with CHF was 55 years, with CAD (38.8%), dilated cardiomyopathy (DCM; 36.5%), and hypertension (10.5%) being the most common etiologies of HF [4]. Severe LV dysfunction was reported in two-thirds of the patients with median N-terminal-pro B-type natriuretic peptide (NT-proBNP) of 29.34.37 pg/mL [4].…”

Section: Introductionmentioning

confidence: 99%

“…For instance, the mean age at diagnosis of patients with CHF was 55 years, with CAD (38.8%), dilated cardiomyopathy (DCM; 36.5%), and hypertension (10.5%) being the most common etiologies of HF [4]. Severe LV dysfunction was reported in two-thirds of the patients with median N-terminal-pro B-type natriuretic peptide (NT-proBNP) of 29.34.37 pg/mL [4]. In addition, at 1 year, the all-cause mortality rate was 9% (cardiac related 93.7%), hospitalization rate was 39%, and emergency room visit was 50%, which could be attributed to the relatively high rate of CHF patients with severe LV dysfunction [4].…”

Section: Introductionmentioning

confidence: 99%

“…Severe LV dysfunction was reported in two-thirds of the patients with median N-terminal-pro B-type natriuretic peptide (NT-proBNP) of 29.34.37 pg/mL [4]. In addition, at 1 year, the all-cause mortality rate was 9% (cardiac related 93.7%), hospitalization rate was 39%, and emergency room visit was 50%, which could be attributed to the relatively high rate of CHF patients with severe LV dysfunction [4].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Saudi Heart Association (SHA) guidelines for the management of heart failure

AlHabeeb

AlAyoubi

Alghalayini

et al. 2019

Journal of the Saudi Heart Association

Self Cite

View full text Add to dashboard Cite

Heart failure (HF) is the leading cause of morbidity and mortality worldwide and negatively impacts quality of life, healthcare costs, and longevity. Although data on HF in the Arab population are scarce, recently developed regional registries are a step forward to evaluating the quality of current patient care and providing an overview of the clinical picture. Despite the burden of HF in Saudi Arabia, there are currently no standardized protocols or guidelines for the management of patients with acute or chronic heart failure. Therefore, the Heart Failure Expert Committee, comprising 13 local specialists representing both public and private sectors, has developed guidelines to address the needs and challenges for the diagnosis and treatment of HF in Saudi Arabia. The ultimate aim of these guidelines is to assist healthcare professionals in delivering optimal care and standardized clinical practice across Saudi Arabia.

show abstract

“…The Gulf acute HF registry (Gulf CARE) surveyed acute HF admissions in seven Arabian Gulf countries, while the Heart Function Assessment Registry Trial in Saudi Arabia, studied acute and high-risk chronic HF admitted to hospital or visiting HF clinics in Saudi Arabia. [910] However, there is still a paucity of regional data concerning the characteristics and management of ambulatory patients with chronic HF.…”

Section: Introductionmentioning

confidence: 99%

Design and rationale of gulf documentation of ambulatory sick patients with heart failure (Gulf DYSPNEA) registry

et al. 2018

View full text Add to dashboard Cite

Aim: The aim of this study is to describe the clinical characteristics of ambulatory patients with chronic heart failure (HF) in the Arabian Gulf and to examine several aspects including types of HF, causes, and adherence to management guidelines. Methods: Gulf documentation of ambulatory sick patients with HF (Gulf DYSPNEA) registry is a multicenter, cross-sectional study, recruiting adult ambulatory HF patients from 24 hospitals in five Arabian Gulf countries. Consecutive patients are recruited prospectively from participating clinics with no follow-up data collection. Recruitment started on November 07, 2016 and will stop when 3,500 patients are enrolled in this study. Collected data explore demographics, baseline patient characteristics, symptoms, previous medical history, comorbidities, physical signs, presenting electrocardiogram, echocardiographic findings, types of HF, and management. Conclusion: This registry is expected to provide useful data on several important aspects and features of ambulatory patients with chronic HF in Arabian Gulf countries. The trial registration number is “ClinicalTrials.gov number, NCT02793180”.

show abstract

Clinical characteristics, management and outcomes of patients with chronic heart failure: Results from the heart function assessment registry trial in S audi Arabia (HEARTS-chronic)

Cited by 26 publications

References 21 publications

<p>Predictors of Mortality in Patients with Chronic Heart Failure: Is Hyponatremia a Useful Clinical Biomarker?</p>

<p>Predictors of Mortality in Patients with Chronic Heart Failure: Is Hyponatremia a Useful Clinical Biomarker?</p>

Saudi Heart Association (SHA) guidelines for the management of heart failure

Design and rationale of gulf documentation of ambulatory sick patients with heart failure (Gulf DYSPNEA) registry

Contact Info

Product

Resources

About